Clinical Trials Logo

Essential Hypertension clinical trials

View clinical trials related to Essential Hypertension.

Filter by:

NCT ID: NCT00295555 Completed - Diabetes Mellitus Clinical Trials

Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy

Start date: January 2004
Phase: Phase 4
Study type: Interventional

Few studies have reported the effect of alpha1-adrenergic antagonists on 24-h blood pressure and regulation of sympathetic nervous activity in hypertensive patients with diabetic nephropathy. Using ambulatory blood pressure monitoring devices equipped with spectral analysis of heart rate variability, we assess the effects of doxazosin on blood pressure in diabetic nephropathy patients and compare the results with those in patients with essential hypertension, patients with diabetes mellitus and patients with chronic nephropathy.

NCT ID: NCT00288184 Completed - Clinical trials for Essential Hypertension

Uric Acid in Essential Hypertension in Children

Start date: September 2004
Phase: Phase 2
Study type: Interventional

The study is a randomized, double-blinded, placebo controlled, crossover trial of allopurinol for the treatment of children with newly diagnosed essential hypertension.

NCT ID: NCT00286884 Completed - Healthy Clinical Trials

Heart Rate Variability in White Coat Hypertension and Essential Hypertension

Start date: n/a
Phase: N/A
Study type: Observational

The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.

NCT ID: NCT00254475 Completed - Clinical trials for Hypercholesterolemia

A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia

Start date: November 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to provide data on the dose response of simvastatin in lowering LDL-C when it is co-administered with valsartan in patients with both essential hypertension and hypercholesterolemia. The primary objective of the study will be to show that the combination of valsartan 160mg/simvastatin 40mg has superior efficacy compared to the combination of valsartan 160mg/simvastatin 20mg in percentage change from baseline in LDL-C.

NCT ID: NCT00220233 Completed - Clinical trials for Essential Hypertension

Olmesartan as an add-on to Amlodipine in Hypertension

Start date: April 2005
Phase: Phase 3
Study type: Interventional

This study is to test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with amlodipine alone

NCT ID: NCT00220220 Completed - Clinical trials for Essential Hypertension

Amlodipine as add-on to Olmesartan in Hypertension

Start date: April 2005
Phase: Phase 3
Study type: Interventional

Test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with olmesartan alone.

NCT ID: NCT00208104 Terminated - Clinical trials for Essential Hypertension

Motivational Interviewing

Start date: July 2002
Phase: N/A
Study type: Interventional

The purpose of this project is to study ways to make it more likely that patients will take their blood pressure medicine as recommended by their doctors.

NCT ID: NCT00185185 Completed - Clinical trials for Essential Hypertension

Olmesartan Medoxomil in Atherosclerosis

Start date: November 2001
Phase: Phase 3
Study type: Interventional

This is a study in hypertensive patients with atherosclerosis and increased cardiovascular risk. The efficacy of olmesartan medoxomil on atherosclerosis is measured.

NCT ID: NCT00185172 Completed - Clinical trials for Essential Hypertension

Olmesartan in Essential Hypertension

Start date: January 2002
Phase: Phase 3
Study type: Interventional

To test the efficacy and safety of olmesartan in patients with essential hypertension.

NCT ID: NCT00157963 Completed - Clinical trials for Essential Hypertension

Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)

Start date: February 5, 2005
Phase: Phase 4
Study type: Interventional

An efficacy and safety study of hydrochlorothiazide (+) losartan potassium compared to amlodipine at week 12 in Korean patients with essential hypertension